if they get FDA approval which de risks the business and growth profile what can we expect ?
2 times revenue say $125m (20% growth?) 32.5c?
3 times 49 cents ?
what's everyone's thoughts?
I guess q1 4C will also help direction as we will see growth numbers
the fact that BUBs had to use emergency stock due to a competitor being out of stock bodes well for approval given that was one of the issues why BUBs got access to the market in the first place
you assume it makes them a takeover target given their low market cap. #1 on Amazon is nothing to be sneezed at
if they get FDA approval which de risks the business and growth...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.010(6.45%) |
Mkt cap ! $147.3M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 15.5¢ | $103.5K | 648.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 2917082 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 709580 | 12 |
View Market Depth
| Last trade - 16.10pm 09/09/2025 (20 minute delay) ? |
| BUB (ASX) Chart |